Key result
A <2-hour invasive strategy for NSTEMI shows no benefit over >2 hours for major events.
Why the study?
Optimal timing for an invasive strategy in NSTEMI is unclear, and whether outcomes improve with less than two versus greater than two hour invasive strategy remains to be determined.
Does a less than two hour invasive strategy improve clinical outcomes compared to a greater than two hour strategy in patients with NSTEMI?
Meta-Analysis (n=1,075)
Does a less than two hour invasive strategy improve clinical outcomes compared to a greater than two hour strategy in patients with NSTEMI?
An invasive strategy within 2 hours for NSTEMI does not significantly improve mortality, MI, or major bleeding compared to a delayed strategy (>2 hours).
Answers are grounded in this paper and cite their sources.
No benefit from <2-hour invasive strategy in NSTEMI; confirms risk-stratified timing over ultra-early intervention.
BACKGROUND: Optimal timing for an invasive strategy in non-ST elevation myocardial infarction (NSTEMI) is unclear. Whether clinical outcomes are improved with a less than two (LT2) compared with greater than two hour (GT2) invasive strategy remains to be determined. We performed a meta-analysis of randomized controlled trials (RCTs) comparing LT2 vs GT2 for NSTEMI. METHODS: A comprehensive literature search for RCTs comparing LT2 vs. GT2 in NSTEMI patients was performed. Three eligible studies consisting of 1,075 patients (LT2: 537, GT2: 538) with NSTEMI were identified. Follow-up ranged from 1 to 12 months. RESULTS: Time from randomization to sheath insertion ranged from 0.5-2.2 and 14.0-85.0 hours in the LT2 and GT2 groups. More percutaneous coronary interventions and fewer coronary artery bypass grafting were performed in the LT2 vs. GT2 group. There was no significant difference in all-cause mortality, myocardial infarction (MI), and major bleeding between the two groups. LT2 was numerically, but not statistically superior to GT2 at preventing recurrent ischemia/urgent revascularization/refractory ischemia. CONCLUSION: Our meta-analysis found no significant difference in outcomes between less than two versus greater than two hours invasive strategy for NSTEMI. The differences observed in the mode of revascularization according to timing of catheterization deserve further study.
No takes yet. Share an insight, caveat, or question.
Velagapudi et al. (2017) conducted a meta-analysis in Non-ST elevation myocardial infarction (NSTEMI) (n=1,075). Less than two hour (LT2) invasive strategy vs. Greater than two hour (GT2) invasive strategy was evaluated on All-cause mortality, myocardial infarction (MI), and major bleeding. A less than two hour invasive strategy for NSTEMI showed no significant difference in all-cause mortality, myocardial infarction, or major bleeding compared to a greater than two hour strategy.
Synapse has enriched 10 related papers. Consider them for comparative context: